Gastric adenocarcinoma presenting with intestinal pseudoobstruction, successfully treated with octreotide.
Intestinal pseudoobstruction has been reported as a paraneoplastic manifestation of several cancers, including those of gastrointestinal tract. Octreotide, a somatostatin analogue, has been used successfully in the treatment of idiopathic and scleroderma-associated intestinal pseudoobstruction. We report a 65-year-old man with carcinoma stomach presenting with intestinal pseudoobstruction, which responded to octreotide.
Sharma
Sanjay
S
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Ghoshal
Uday C
UC
Bhat
Ganesh
G
Choudhuri
Gourdas
G
D000230:Adenocarcinoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000209:etiology*; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011859:Radiography; D013274:Stomach Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D015282:Octreotide